Cargando…

Anthropometric indicators of visceral adiposity as predictors of non-alcoholic fatty liver disease: A review

The objective was to critically analyze studies that evaluated the predictive capacity of indicators of visceral adiposity in non-alcoholic fatty liver disease (NAFLD). The bibliographic research was carried out using the electronic database PubMed, LILACS and SciELO, references of selected articles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almeida, Naiade Silveira, Rocha, Raquel, Cotrim, Helma Pinchemel, Daltro, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206145/ https://www.ncbi.nlm.nih.gov/pubmed/30386462 http://dx.doi.org/10.4254/wjh.v10.i10.695

Ejemplares similares

Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
por: Almeida, Naiade Silveira, et al.
Publicado: (2022)

Chronic kidney disease and the severity of non-alcoholic fatty liver disease: a systematic review
por: Carvalho, Kellyane Santana Dias, et al.
Publicado: (2023)

Diet and intestinal bacterial overgrowth: Is there evidence?
por: Souza, Claudineia, et al.
Publicado: (2022)

From Nonalcoholic Steatohepatits to Steatotic Liver Disease: A Long Way
por: Cotrim, Helma Pinchemel
Publicado: (2023)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Oral health related-quality of life before and during the COVID-19 pandemic in patients with non-alcoholic fatty liver disease
por: Aguiar, Inácio Lima Silva, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
por: Amato, Marco Calogero, et al.
Publicado: (2014)

Racial differences in prevalence and severity of non-alcoholic fatty liver disease
por: Bonacini, Maurizio, et al.
Publicado: (2021)

Therapies for non-alcoholic fatty liver disease: A 2022 update
por: Shen, Katie, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach
por: Perez-Carreras, Mercedes, et al.
Publicado: (2021)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

Relationship between non-alcoholic fatty liver disease and coronary heart disease
por: Arslan, Ugur, et al.
Publicado: (2020)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
por: Sheng, Wei, et al.
Publicado: (2022)

Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
por: Wang, Dan, et al.
Publicado: (2023)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Visceral adiposity indicators as predictors of metabolic syndrome in postmenopausal women
por: Anık İlhan, Gökçe, et al.
Publicado: (2019)

Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
por: Pal, Shreya C, et al.
Publicado: (2023)

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
por: Chen, Hui-Ting, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
por: Wajsbrot, Natalia Balassiano, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
por: Mattos, Ângelo Z, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
por: Dietrich, Christoph G, et al.
Publicado: (2023)

Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?
por: Janota, Barbara, et al.
Publicado: (2023)

Evaluation of the Accuracy of Anthropometric Clinical Indicators of Visceral Fat in Adults and Elderly
por: Roriz, Anna Karla Carneiro, et al.
Publicado: (2014)

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020)

A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease
por: Skat‐Rørdam, Josephine, et al.
Publicado: (2019)

The CUN-BAE, Deurenberg Fat Mass, and visceral adiposity index as confident anthropometric indices for early detection of metabolic syndrome components in adults
por: López-González, A. A., et al.
Publicado: (2022)

Hepatocellular carcinoma in patients with B and C virus hepatitis without cirrhosis
por: Carvalho, Kellyane Santana Dias, et al.
Publicado: (2017)

Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article
por: Chao, Che-Yung, et al.
Publicado: (2016)

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
por: Leoni, Simona, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics
por: Trovato, Guglielmo M
Publicado: (2020)

Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
por: Anirvan, Prajna, et al.
Publicado: (2021)

Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
por: Bilic-Curcic, Ines, et al.
Publicado: (2021)

Visceral Adiposity and Anthropometric Indicators as Screening Tools of Metabolic Syndrome among Low Income Rural Adults in Xinjiang
por: Guo, Shu-xia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vem81u4qrsg82qfce395scnacb